Novelion Therapeutics Inc (NASDAQ:NVLN)

4.49
Delayed Data
As of May 21
 +0.06 / +1.35%
Today’s Change
3.08
Today|||52-Week Range
10.68
+43.91%
Year-to-Date
No recent news for Novelion Therapeutics Inc.

Today’s Trading

Previous close4.43
Today’s open4.47
Day’s range4.25 - 4.50
Volume92,816
Average volume (3 months)47,466
Market cap$76.5M
Data as of 4:00pm ET, 05/21/2018

Growth & Valuation

Earnings growth (last year)-45.20%
Earnings growth (this year)+0.31%
Earnings growth (next 5 years)+74.60%
Revenue growth (last year)+919.88%
P/E ratioNM
Price/Sales0.42
Price/Book5.12

Competitors

 Today’s
change
Today’s
% change
CDTXCidara Therapeutics ...-0.15-3.19%
CTSOCytosorbents Corp0.000.00%
CDXCChromadex Corp-0.18-4.64%
NATRNatures Sunshine Pro...-0.30-3.17%
Data as of 4:00pm ET, 05/21/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$138.4M
Annual profit (last year)-$126.7M
Net profit margin-91.53%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Operating Officer &
Executive VP
Jeffrey Hackman
Chief Financial Officer &
Senior Vice President
Michael Dennis Price
Corporate headquarters
Vancouver, British Columbia

Forecasts